How monkeys block HIV

Credit: © KAREN KASMAUSKI/CORBIS" /> Credit: © KAREN KASMAUSKI/CORBIS HIV-1 is unable to replicate in Old World monkeys, even though it can enter their cells. In 2004, Joseph Sodroski at Dana-Farber Cancer Institute in Boston and his colleagues identified the factor responsible. They transduced human cells with a complementary DNA (cDNA) library prepared from rhesus monkeys. Resistant cells commonly harbored cDNA for the cytoplasmic body component TRIM5α. The research revealed a

Written byCharles Q. Choi
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

HIV-1 is unable to replicate in Old World monkeys, even though it can enter their cells. In 2004, Joseph Sodroski at Dana-Farber Cancer Institute in Boston and his colleagues identified the factor responsible. They transduced human cells with a complementary DNA (cDNA) library prepared from rhesus monkeys. Resistant cells commonly harbored cDNA for the cytoplasmic body component TRIM5α. The research revealed an intracellular immunity mechanism to viruses "we didn't realize existed before," Sodroski says. TRIM5α possesses at its C-terminal end a domain with variable regions on it "similar to immunoglobulin," he adds.

The identity of a factor in primates that blocked HIV-1, "was the hottest topic of its time in the retrovirus field," recalls Stephen Goff at Columbia University in New York. Much work has since gone into how it works. "We've found TRIM5 recognizes viral capsids in a fairly specific way," Sodroski says. "We believe TRIM5 stops HIV infection ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies